Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone in Severe H1N1 Pneumonia
NCT01014364Phase 3Terminated
- Sponsor
- Université de Versailles Saint-Quentin-en-Yvelines
- Start
- Mar 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in viral pneumonia, H1N1 influenza (H1N1), sponsored by Université de Versailles Saint-Quentin-en-Yvelines. Started Mar 2010; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
viral pneumoniaH1N1 influenza (H1N1)
Beyond the preview
Go deeper on NCT01014364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014364.